HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott B Patten Selected Research

Neurocognitive Disorders (Clerambault Syndrome)

3/2022Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott B Patten Research Topics

Disease

18Multiple Sclerosis
10/2023 - 01/2002
15Anxiety Disorders (Anxiety Disorder)
01/2023 - 10/2005
8Mental Disorders (Mental Disorder)
01/2023 - 09/2005
6Pain (Aches)
12/2023 - 01/2003
6Major Depressive Disorder (Major Depressive Disorders)
12/2022 - 01/2008
6Migraine Disorders (Migraine)
04/2019 - 10/2005
6Epilepsy (Aura)
01/2019 - 05/2010
6Depressive Disorder (Melancholia)
12/2018 - 07/2004
5Neoplasms (Cancer)
10/2023 - 05/2006
5Mood Disorders (Mood Disorder)
03/2017 - 11/2004
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022 - 01/2019
4Dementia (Dementias)
03/2022 - 07/2013
4Bipolar Disorder (Manic Depressive Psychosis)
12/2020 - 10/2017
4Schizophrenia (Dementia Praecox)
10/2019 - 10/2011
4Cognitive Dysfunction
01/2017 - 08/2008
3Alzheimer Disease (Alzheimer's Disease)
03/2022 - 07/2013
3Psychotic Disorders (Schizoaffective Disorder)
01/2021 - 01/2014
3Hypertension (High Blood Pressure)
07/2018 - 04/2009
3Chronic Disease (Chronic Diseases)
10/2010 - 01/2003
2COVID-19
10/2022 - 10/2021
2Rheumatoid Arthritis
01/2022 - 01/2018
2Substance-Related Disorders (Drug Abuse)
12/2021 - 12/2020
2Alcoholism (Alcohol Abuse)
12/2021 - 01/2015
2Wounds and Injuries (Trauma)
11/2021 - 05/2010
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2019 - 12/2011
2Frailty
01/2016 - 09/2012
2Weight Gain
05/2015 - 11/2011
2Relapsing-Remitting Multiple Sclerosis
01/2015 - 01/2002
1Fatigue
12/2023
1Multiple Chronic Conditions
01/2023
1Mania (Manias)
12/2022
1Critical Illness (Critically Ill)
10/2022
1Huntington Disease (Huntington's Disease)
03/2022
1Neurocognitive Disorders (Clerambault Syndrome)
03/2022
1Parkinson Disease (Parkinson's Disease)
03/2022
1Marijuana Abuse (Cannabis Abuse)
12/2021
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2021
1Occupational Stress
11/2021
1Sexual Trauma
11/2021
1Human Influenza (Influenza)
04/2021
1Social Phobia
01/2020
1Autistic Disorder (Autism)
12/2019
1Conduct Disorder (Conduct Disorders)
12/2019
1Psoriatic Arthritis
11/2019
1Crohn Disease (Crohn's Disease)
01/2019
1Abdominal Obesity
07/2018
1Autoimmune Diseases (Autoimmune Disease)
01/2018

Drug/Important Bio-Agent (IBA)

20Antidepressive Agents (Antidepressants)IBA
12/2022 - 01/2003
103,4-methylenedioxyethamphetamine (MDEA)IBA
11/2021 - 11/2005
94-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
12/2023 - 10/2014
5Antipsychotic Agents (Antipsychotics)IBA
12/2019 - 10/2011
4BenzodiazepinesIBA
12/2022 - 01/2008
3Immunomodulating AgentsIBA
01/2022 - 10/2017
3insulin receptor-related receptor (IRR)IBA
10/2019 - 10/2017
3SmokeIBA
12/2018 - 05/2010
2Indicators and Reagents (Reagents)IBA
01/2023 - 09/2005
2Opioid Analgesics (Opioids)IBA
01/2023 - 08/2008
2Quetiapine Fumarate (Seroquel)FDA Link
03/2015 - 10/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2014 - 07/2004
2Interferon beta-1aFDA Link
04/2005 - 01/2002
11-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2023
1ElectrolytesIBA
12/2022
1Cycloserine (Seromycin)FDA Link
12/2022
1CreatinineIBA
12/2022
1CannabinoidsIBA
03/2022
1mesoglycanIBA
03/2022
1CannabidiolIBA
03/2022
1Caffeine (No Doz)FDA LinkGeneric
12/2021
1antineoplaston A10 (A 10)IBA
12/2021
1VaccinesIBA
04/2021
1Medical MarijuanaIBA
01/2021
1Guanfacine (Tenex)FDA LinkGeneric
12/2019
1gamma-glutamylaminomethylsulfonic acid (GAMS)IBA
04/2019
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
01/2019
1Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
01/2019
1Mirtazapine (Rexer)FDA LinkGeneric
01/2019
1Levetiracetam (Keppra)FDA LinkGeneric
01/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2019
1Serotonin (5 Hydroxytryptamine)IBA
01/2019
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
01/2019
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2019
1Second-Generation Antidepressive AgentsIBA
01/2019
1CholesterolIBA
07/2018
1CytokinesIBA
01/2018
1Carbamazepine (Tegretol)FDA LinkGeneric
01/2018
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2018

Therapy/Procedure

15Therapeutics
10/2023 - 04/2005
2Aftercare (After-Treatment)
11/2022 - 01/2016
2Personal Protective Equipment
10/2022 - 10/2021
2Long-Term Care
07/2015 - 09/2012
2Drug Therapy (Chemotherapy)
07/2013 - 08/2008
2Complementary Therapies (Alternative Medicine)
10/2010 - 10/2009
1Polypharmacy
01/2023
1Transcranial Magnetic Stimulation
12/2022
1Critical Care (Surgical Intensive Care)
10/2022
1Patient Readmission
12/2021
1Biological Therapy
01/2020
1Arthroplasty
11/2019
1Home Nursing (Nursing, Home)
01/2018
1Activities of Daily Living (ADL)
01/2018